A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome‐positive chronic myeloid leukemia in chronic phase: ENESTKorea

Cancer Medicine, EarlyView.


from Cancer via ola Kala on Inoreader https://ift.tt/2GhUhDX
via IFTTT